Skip to main content
Premium Trial:

Request an Annual Quote

Visible Genetics Completes $7 Million Private Financing

Premium

TORONTO--Visible Genetics announced the completion of a $7 million debt financing with a group of private and institutional investors. The maker and marketer of high-performance automated DNA sequencing systems here said the funds will be used for expansion of its international sales and marketing operations, research and development, and for general working capital purposes. The company will now focus on further expanding the company's presence in the HIV, HPV, and HLA genotyping areas, as well as work to develop new applications for its technologies and products, President John Stevens said.

The loan bears interest at an annual rate of 10 percent and is due in 12 months. In addition, the investors received 420,000 warrants to purchase an equivalent number of common shares until April 29, 2003 at $10 per share.

Filed under

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.